{"id":"https://openalex.org/W2590218510","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","title":"A double-blind, randomized, multicenter study regarding the effects of solution for gemcitabine on frequency and degree of vascular pain in patients with cancer.","display_name":"A double-blind, randomized, multicenter study regarding the effects of solution for gemcitabine on frequency and degree of vascular pain in patients with cancer.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590218510","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","mag":"2590218510"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.e19642","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102821926","display_name":"Hiroki Nagai","orcid":"https://orcid.org/0000-0003-1673-2647","observed_orcids":["https://orcid.org/0000-0003-1673-2647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Nagai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028501439","display_name":"Hiroaki Yasuda","orcid":"https://orcid.org/0000-0002-8346-9853","observed_orcids":["https://orcid.org/0000-0002-8346-9853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Yasuda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015679349","display_name":"Masashi Kanai","orcid":"https://orcid.org/0000-0002-6954-4474","observed_orcids":["https://orcid.org/0000-0002-6954-4474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Kanai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110078775","display_name":"T. Nishimura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Nishimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062492623","display_name":"Toshiyuki Kitano","orcid":"https://orcid.org/0000-0002-4194-1638","observed_orcids":["https://orcid.org/0000-0002-4194-1638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Kitano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Matsumoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Matsumoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112077752","display_name":"Yoshiaki Mori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Mori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"H. Ishiguro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Ishiguro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004342375","display_name":"Yuichi Kakudo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Kakudo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031936902","display_name":"Hiroki Sato","orcid":"https://orcid.org/0000-0002-3346-5053","observed_orcids":["https://orcid.org/0000-0002-3346-5053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Sato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048025014","display_name":"Takashi Yamaguchi","orcid":"https://orcid.org/0000-0001-5153-940X","observed_orcids":["https://orcid.org/0000-0001-5153-940X","https://orcid.org/0009-0004-6294-8005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Yamaguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055120136","display_name":"S. Takashima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Takashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"K. Nakata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Nakata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068664988","display_name":"Takayuki Terada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Terada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102920096","display_name":"Takaaki Sasaki","orcid":"https://orcid.org/0000-0002-6505-8786","observed_orcids":["https://orcid.org/0000-0002-6505-8786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Sasaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042788234","display_name":"Tomohiko Mio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Mio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055633296","display_name":"Mamori Mishima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Mishima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053041120","display_name":"Kazuyoshi Yanagihara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Yanagihara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M. Fukushima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fukushima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"e19642","last_page":"e19642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.6259999871253967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.6259999871253967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.20800000429153442,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","score":0.09279999881982803,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/vascular-pain","display_name":"vascular pain","score":0.9350000023841858},{"id":"https://openalex.org/keywords/drug-dissolution","display_name":"drug dissolution","score":0.367000013589859},{"id":"https://openalex.org/keywords/5-glucose-solution","display_name":"5% glucose solution","score":0.9829999804496765},{"id":"https://openalex.org/keywords/saline-solution","display_name":"saline solution","score":0.9800000190734863},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9237027168273926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.891678512096405},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.6655948162078857},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5813283920288086},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5298274159431458},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5043731927871704},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4746984839439392},{"id":"https://openalex.org/C2778904085","wikidata":"https://www.wikidata.org/wiki/Q3712728","display_name":"Cancer pain","level":3,"score":0.4543028771877289},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4533284902572632},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3442475199699402},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27904677391052246},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07355669140815735},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.05568414926528931},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.e19642","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.e19642","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1966334658","https://openalex.org/W4200307359","https://openalex.org/W2757010182","https://openalex.org/W2051007683","https://openalex.org/W2024602384","https://openalex.org/W3010145798","https://openalex.org/W2152993546","https://openalex.org/W3093847331","https://openalex.org/W2127495944","https://openalex.org/W2757336296"],"abstract_inverted_index":{"e19642":[0],"Background:":[1],"Gemcitabine":[2,295],"is":[3],"an":[4],"active":[5],"anticancer":[6],"drug":[7],"approved":[8,171],"for":[9,21,49,85,195,274],"various":[10],"kinds":[11],"of":[12,35,45,51,55,61,76,101,106,134,145,159,164,167,197,200,221,251,270,276,286,292],"cancers":[13],"and":[14,83,99,120,137,143,179,189,258,282],"has":[15],"relatively":[16],"few":[17],"adverse":[18],"events":[19],"except":[20],"bone":[22],"marrow":[23],"toxicity,":[24],"but":[25],"we":[26,40,89,190],"have":[27],"sometimes":[28],"experienced":[29],"vascular":[30,56,77,102,135,146,160,201,222,252,287],"pain":[31,57,78,103,161,202,223,253,288],"during":[32,104,162],"intravenous":[33],"administration":[34,105,163],"gemcitabine.":[36,165],"In":[37],"retrospective":[38],"analysis,":[39],"reported":[41],"that":[42,60,212,233],"the":[43,72,97,138,157,280,284],"use":[44,269],"5%":[46,80,207,228,255,271,302],"glucose":[47,81,208,229,256,272,303],"solution":[48,63,82,209,215,230,236,257,260,273],"dissolution":[50,275],"gemcitabine":[52,86,107,277],"decreased":[53,205,279],"frequency":[54,98,133,281],"compared":[58,210,231,289],"with":[59,211,232,290,301],"saline":[62,84,214,235,259,293],"for.":[64],"However,":[65],"there":[66],"were":[67,113,141,186],"no":[68,245],"reports":[69],"which":[70],"demonstrated":[71],"difference":[73,248],"in":[74,115,175,206,213,227,234,249],"frequencies":[75],"between":[79,108,254],"dissolution.":[87],"Therefore,":[88],"conducted":[90],"this":[91,168],"double-blind":[92],"randomized":[93],"study":[94,122,169],"to":[95,126,149,155,298],"compare":[96],"degree":[100,142,158,285],"them.":[109],"Methods:":[110],"Ninety":[111],"patients":[112,185],"enrolled":[114],"a":[116],"double-blind,":[117],"randomized,":[118],"crossover,":[119],"multicenter":[121],"from":[123],"July":[124],"2009":[125],"June":[127],"2010.":[128],"The":[129,268],"primary":[130],"endpoint":[131],"was":[132,153,170,203,224,244],"pain,":[136],"secondary":[139],"endpoints":[140],"duration":[144,250],"pain.":[147],"Zero":[148],"10":[150],"numerical":[151],"scale":[152],"used":[154,191],"estimate":[156],"Performance":[166],"by":[172],"ethic":[173],"committee":[174],"Tohoku":[176],"University":[177,181],"(ID:2008-471)":[178],"Kyoto":[180],"(ID:C-295).":[182],"Results:":[183],"Eighty-seven":[184],"randomly":[187],"assigned,":[188],"decentralized":[192],"robust":[193],"method":[194],"analysis":[196],"data.":[198],"Frequency":[199],"significantly":[204,278],"(40%":[216],"versus":[217,240,263],"63%,":[218],"p<0.001).":[219,242],"Degree":[220],"also":[225],"relieved":[226,283],"(pain":[237],"score":[238],"1.3":[239],"2.7,":[241],"There":[243],"significant":[246],"statistic":[247],"(21":[261],"minutes":[262],"18":[264],"minutes,":[265],"p=0.420).":[266],"Conclusions:":[267],"those":[291],"solution.":[294,304],"may":[296],"prefer":[297],"be":[299],"dissolved":[300],"ICMJE":[305],"number,":[306],"UMIN000001827.":[307]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-03T00:00:00"}